PTG.WA
Price:
$26.2
Market Cap:
$122.18M
Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases using T-regulatory cells. It engages in the research and development of therapies for the treatment of type 1 diabetes in children and in multiple sclerosis. The company is based in Gdansk, Poland.
Industry
Biotechnology
IPO Date
2021-11-23
Stock Exchange
WSE
Ticker
PTG.WA
According to Poltreg S.A.’s latest financial reports and current stock price. The company's current ROE is -37.19%. This represents a change of 287.22% compared to the average of -9.60% of the last 4 quarters.
The mean historical ROE of Poltreg S.A. over the last ten years is 2.27%. The current -37.19% ROE has changed -101.64% with respect to the historical average. Over the past ten years (40 quarters), PTG.WA's ROE was at its highest in in the March 2020 quarter at 3.82%. The ROE was at its lowest in in the June 2025 quarter at -15.32%.
Average
2.27%
Median
-6.84%
Minimum
-176.70%
Maximum
16.12%
Discovering the peaks and valleys of Poltreg S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 695.38%
Maximum Annual ROE = 16.12%
Minimum Annual Increase = -9220.84%
Minimum Annual ROE = -176.70%
| Year | ROE | Change |
|---|---|---|
| 2024 | -27.02% | 74.51% |
| 2023 | -15.48% | 695.38% |
| 2022 | -1.95% | -46.35% |
| 2021 | -3.63% | -46.96% |
| 2020 | -6.84% | -100.04% |
| 2019 | 16.12% | -9220.84% |
The current ROE of Poltreg S.A. (PTG.WA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-14.82%
5-year avg
-10.98%
10-year avg
2.27%
Poltreg S.A.’s ROE is greater than Molecure S.A. (-32.20%), greater than Mabion S.A. (-32.43%), greater than NanoGroup S.A. (-57.44%), less than Pure Biologics Spólka Akcyjna (168.05%), less than Medinice S.A. (55.26%), greater than Genomtec S.A. (-104.44%), greater than Urteste S.A. (-17.38%), greater than Pharmena S.A. (-15.06%), greater than Captor Therapeutics Spolka Akcyjna (-77.21%), greater than Airway Medix S.A. (-9.25%),
| Company | ROE | Market cap |
|---|---|---|
| -32.20% | $150.20M | |
| -32.43% | $126.07M | |
| -57.44% | $90.06M | |
| 168.05% | $33.58M | |
| 55.26% | $98.66M | |
| -104.44% | $65.83M | |
| -17.38% | $51.73M | |
| -15.06% | $33.97M | |
| -77.21% | $385.88M | |
| -9.25% | $35.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poltreg S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poltreg S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Poltreg S.A.'s ROE?
How is the ROE calculated for Poltreg S.A. (PTG.WA)?
What is the highest ROE for Poltreg S.A. (PTG.WA)?
What is the 3-year average ROE for Poltreg S.A. (PTG.WA)?
What is the 5-year average ROE for Poltreg S.A. (PTG.WA)?
How does the current ROE for Poltreg S.A. (PTG.WA) compare to its historical average?